Stock listing

NASDAQ:TSRX Trius Therapeutics Inc Stock

Follow Trius Therapeutics Inc into a list and get an email when it puts out news.

Last close · NASDAQ:TSRX

$13.63 USD

Close on Sep 11, 2013 · No longer trades

Aug 3, 2010 to last close +172.6% · weekly closes, Aug 3, 2010 – Sep 11, 2013
Lowest – highest close
$3.02 – $14.10 USDSince Aug 3, 2010 · lowest Dec 6, 2010 · highest Jul 31, 2013

Delisted NASDAQ:TSRX no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:TSRX
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Trius Therapeutics Inc on 6ix

Decks
2 decks · latest Mar 25, 2013

Decks

DeckKindSlidesDate
Technical Presentation (March 2013)Technical15 slidesMar 25, 2013
Corporate Update (January 2012)Corporate update13 slidesJan 3, 2012

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
John Craig Thompson
Other companies: Esperion Therapeutics, Inc. (Director · Since at least Jul 1, 2025); Anthera Pharmaceuticals Inc (President & CEO, Director · Jan 7, 2016 – Jan 5, 2018 · Past); Tetraphase Pharmaceuticals Inc (Chief Operating Officer · Feb 3, 2014 – Sep 8, 2015 · Past)
Chief Commercial Officer · Mar 8, 2012 – Sep 11, 2013 · Past

Open People

Log in to ask 6ix AI your own questions about Trius Therapeutics Inc.